Winning Strategies: How to Create, Grow, and Sustain a Successful Life Sciences Company
Today’s biotech market is experiencing a slow but steady rebound.
But, in today’s market success doesn’t come easy. Excelling in a new financial and regulatory environment demands not only new approaches to raising and sustaining a cash flow and a strong IP and regulatory strategy, but also new models for building multinational collaborations. Bay Area life sciences companies are surviving in this difficult and evolving market and maintain the lead in terms of venture capital funding, cross-national collaborations and innovative product pipelines.
You are invited to join Foley & Lardner LLP, BayBIO, and Ernst & Young for Winning Strategies: How to Create, Grow, and Sustain a Successful Life Sciences Company. During this half-day conference, financial advisors, industry leaders, and legal counsel will provide insight on critical business, regulatory and legal issues during the following interactive panels:
- Post-Recession Life Sciences: Achieving Success in the Current Environment
- Beyond the Nuts & Bolts: Protecting Your IP Assets in Today’s Expanding Global Market
- Match-Making: Identifying Partners, Creative Collaborations and Long Term Outcomes
- Cross-Border R&D in China – Understanding the Regulatory Challenges
Keynote address by James Sabry, M.D., Ph.D and Vice President at Genentech Partnering
With closing remarks by Gail Maderis, President & CEO of BayBio.
Our Supporting Contributors Include:
For additional information, please contact Delia Dai at [email protected].
